Attached files
| file | filename |
|---|---|
| EX-10.8 - EXHIBIT 10.8 - Innovatus Life Sciences Acquisition Corp. | tm215738d6_ex10-8.htm |
| EX-10.4 - EXHIBIT 10.4 - Innovatus Life Sciences Acquisition Corp. | tm215738d6_ex10-4.htm |
| EX-10.3 - EXHIBIT 10.3 - Innovatus Life Sciences Acquisition Corp. | tm215738d6_ex10-3.htm |
| EX-1.1 - EXHIBIT 1.1 - Innovatus Life Sciences Acquisition Corp. | tm215738d6_ex1-1.htm |
| S-1/A - S-1/A - Innovatus Life Sciences Acquisition Corp. | tm215738-5_s1a.htm |
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Innovatus Life Sciences Acquisition Corp. (the “Company”) on Amendment No. 1 to Form S-1 (File No. 333-255075) of our report dated March 5, 2021, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Innovatus Life Sciences Acquisition Corp. as of February 12, 2021 and for the period from January 8, 2021 (inception) through February 12, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
Hartford, CT
June 9, 2021